S07 Neurobiology of Sexual Function and Dysfunction in Women

Program: Symposia
Translational Session
Friday, April 1, 2016: 9:45 AM-11:15 AM
Room 205 (BCEC)
Developed in Collaboration with NICHD
Charisee A Lamar, PhD, MPH, NICHD/NIH, Bethesda, MD

Nothing to Disclose: CAL
9:45 AM
Leah S Millheiser, MD, Stanford Healthcare Gynecology Clinic, Palo Alto, CA
LSM: Chief Scientific Officer, Nuelle, Inc.
10:15 AM
Margaret E Wierman, MD, Dept Medicine, Div Endocrinology, University of Colorado School of Medicine and Research Service VAMC, Aurora, CO
Nothing to Disclose: MEW
10:45 AM
James A. Simon, MD, The George Washington University School of Medicine, Washington, DC
JAS: Advisory Board Member/Consultant, AbbVie, Inc., Advisory Board Member/Consultant, Ascend, Advisory Board Member/Consultant, Noven Pharmaceuticals, Inc., Advisory Board Member/Consultant, Nuelle, Inc., Advisory Board Member/Consultant, Perrigo Company, PLC, Advisory Board Member/Consultant, Sermonix Pharmaceuticals, Inc., Advisory Board Member/Consultant, Shionogi Inc., Advisory Board Member/Consultant, Sprout Pharmaceuticals, Advisory Board Member/Consultant, TherapeuticsMD, Speaker Bureau Member, Noven Pharmaceuticals, Inc., Speaker Bureau Member, Novo Nordisk, Speaker Bureau Member, Shionogti Inc., Researcher, AbbVie, Inc., Researcher, Bayer Healthcare LLC, Researcher, Actavis, PLC, Researcher, New England Research Institute, Inc., Researcher, Novo Nordisk, Researcher, Palatin Technologies, Researcher, TherapeuticsMD, Stockholder (direct purchase), Sesrmonix Pharmaceuticals, Owner/Board of Directors, James A. Simon, MD, PC.
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire